CareLit · DOI-Nachweis · Zeitschrift für Geburtshilfe und Neonatologie
Maternal Serum Periostin as a Potential Biomarker for Gestational Diabetes Mellitus and Adverse Perinatal Outcomes
DOI 10.1055/a-2827-9333
Bibliografische Angaben
Nachweis in CareLit
Autor:innenSemra Eroglu, Neset Gumusburun, Sebati Sinan Urkmez, Yeşim Civil Ürkmez, Samettin Çelik, Kübra Şahin
ZeitschriftZeitschrift für Geburtshilfe und Neonatologie
Ausgabe05/2026
Jahrgang / SeitenJg. 230 · S. 419-424
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Objective To investigate whether maternal serum periostin levels measured in the second trimester can serve as a biomarker for gestational diabetes mellitus (GDM) and predict perinatal outcomes. Methods This prospective case–control study included 173 pregnant women (103 with GDM and 70 healthy controls). Serum periostin levels were measured between 15–20 weeks of gestation. GDM was diagnosed using a 75-g o…
Zitieren
Zitierempfehlung
Semra Eroglu, Neset Gumusburun, Sebati Sinan Urkmez, Yeşim Civil Ürkmez, Samettin Çelik, Kübra Şahin (2026) Maternal Serum Periostin as a Potential Biomarker for Gestational Diabetes Mellitus and Adverse Perinatal Outcomes. Zeitschrift für Geburtshilfe und Neonatologie, 230 (05), 419-424. https://doi.org/10.1055/a-2827-9333
Mit CareLit weiterarbeiten